by pbn | Jun 22, 2021 | Team Members
Lisa completed her doctorate at the Laboratory of Neurobiology Group at Aalborg University. She investigated neuroinflammation and iron handling in diseases with brain iron overload, such as haemorrhagic stroke and chronic neurodegenerative diseases.
by pbn | Jun 23, 2021 | Team Members
Nicole is responsible for 2N Pharma’s external communication, including our social media presence. She has experience from previous roles in marketing and public relations.
by pbn | Jun 23, 2021 | Press Releases
Aalborg, Denmark, 23 June 2021 – 2N Pharma, a biotech company developing therapeutic drugs to treat neurological disorders, today announced the appointment of Alex Leech as Chair of the Board of Directors and John Kemp as Non-Executive Director. “We are...
by pbn | Jun 23, 2021 | Board of Directors
Alex Leech was the founding CEO of Alchemab Therapeutics and raised a £60m ($82m) Series A in 2021. He is a serial biotech CEO having led Creabilis, a leading European dermatology company, until its acquisition by Sienna Biopharmaceuticals Inc. in December 2016 and...
by pbn | Jun 23, 2021 | Board of Directors
John Kemp is currently the CSO of Syndesi Therapeutics. Former roles include Head of Neuroscience Discovery at Janssen, Belgium, and CEO of Evotec Neurosciences, which was spun-out from Evotec and raised a €25m Series A in 2004. Before joining Evotec, John was SVP and...
Recent Comments